Pfizer threatened with product-hopping fine in Chile
Pfizer’s Chilean subsidiary could face a near US$20,000 fine after Chile’s competition enforcer requested that the country’s competition court impose the heaviest possible punishment for alleged abusive practices related to a drug patent.
To read more
Subscribe to Latin Lawyer
Subscribe and start reading now
Latin Lawyer is your definitive source of news, analysis, and research from the Latin American legal community. It keeps you up to speed with the issues and trends that matter and provides the data and tools you need to operate successfully.